EIKN · ISSUER CIK 1861123
Eikon Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Eikon Therapeutics, Inc. insiders reported $1.0M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Column Group IV GP, LP (10% Owner), with $1.0M.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$1.0MInsider buying
$0.00Insider selling
+$1.0MNet open-market
Sep 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 202616:33 | Sep 3, 2026 | EIKN | 10% Owner · +7 joint | P · BuyLate 5d | $11.56 | +89,200 | 89,200 | New | +$1.0M | -11.4% | -53.7% |